Renal AT2R Are A Therapeutic Target For The Treatment Of Hypertension In Women
Funder
National Health and Medical Research Council
Funding Amount
$605,939.00
Summary
Being female is associated with better renal function, resistenace to renal injury and hypertension, but it is not understood why. Our work demonstrates that women have more angiotensin type 2 receptors (AT2R) in the kidney then men. In men AT2R have been suggested to protect against hypertension and renal damage. We predict that the effects of AT2R stimulation will be greater in women and therefore the protective benefits greater.